Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers By functional area All functional areas Clinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Clinical ResearchPhase 1 - Phase 4 Tumor-Agnostic Treatments: A Game Changer for Rare Oncology Trials By Premier Research October 28, 2020 Clinical ResearchPhase 1 - Phase 4 Resources for Childhood Cancer Awareness Month By Premier Research September 22, 2020 Consulting Long-Term Follow-Up in Gene Therapy Trials: Ensuring Patient Engagement & Regulatory Compliance By Premier Research July 17, 2020 COVID-19 Global Health Authorities Push for Rapid Development of COVID-19 Tests, Drugs and Vaccines By Premier Research March 20, 2020 COVID-19 Considerations for Ensuring Trial Continuity in the Wake of COVID-19 By Premier Research March 18, 2020 Clinical ResearchPhase 1 - Phase 4 Considerations for Operationalizing Pediatric Oncology Studies By Premier Research December 18, 2019 Previous 1 2 3 4 5 … 16 Next × ALSO OF INTEREST3 of the Hardest Obstacles We Face in...Alternative Designs to the Traditional 3+3...Leveraging Real-World Data & Real-World...
